5th Global Meeting on Implementing New and Under-utilized Vaccines, 22-24 June 2011
The fifth WHO Global Meeting on Implementing New and Under-utilized Vaccines (NUVI) was held in Montreux, Switzerland from 22-24 June 2011 with over 125 participants including representatives from Ministries of Health from 18 countries, WHO, UNICEF (HQ, Regional and Country offices), partner agencies including Agence de Médecine Préventive, The Bill and Melinda Gates Foundation, CDC, Clinton Health Access Initiative, GAVI Secretariat, John Snow International (MCHIP), NORAD, PATH, Sabin Institute, the SIVAC Initiative, and USAID, as well as participants from eight universities, four NGOs, six manufacturers, and independent consultants.
The overall theme of the NUVI meeting was "Sustaining the gains of new vaccine introduction" with the objectives to review and discuss key issues in new and under-utilized vaccine introduction among immunization partners, regions and countries. The meeting had plenary sessions to discuss the progress with the Global NUVI Plan of Action, update from GAVI on NUVI financing, lessons learned from new vaccines introduction to date, and keynote speeches on "Sustaining the Gains". The meeting also hosted six workshops on the following key areas: Prioritization of vaccines at the country level; Communication for NUVI; Vaccine Supply & Pricing; Delivery Strategies for Typhoid, JE, Rubella and HPV vaccines; Immunization Schedules; and Human Resources for Immunization.
Priorities to be undertaken by WHO/UNICEF and different partner institutions in the coming year were identified. The meeting concluded that rotavirus and pneumococcal vaccine introductions should be prioritized, followed by preparations for HPV introduction and support for the introduction of underused regional vaccines such as Yellow Fever, Japanese Encephalitis, Meningitis A, Typhoid and Cholera vaccines. Meeting participants, in a final voting session, also prioritized the following supportive tasks for the year to come: To make vaccines more affordable, to strengthen immunization delivery systems, to increase national ownership and financing of NUVI, to improve human resources for immunization and to improve surveillance data quality as well as the development of integrated surveillance platforms.
The theme conclusion was that all partners will need to hold themselves accountable for results, that more work is to be done on demand generation and community engagement, that the momentum with donors be maintained with a focus on critical messages that "we can deliver", that more needs to be done to respond to the needs of lower middle-income countries and that, overall, the new vaccines momentum should be better used to strengthen immunization systems.
- Introductory session
- Workgroup 1. Prioritization of vaccines at country level
- Workgroup 2. Communication for NUVI
- Workgroup 3. The Vaccine Supply and Pricing Situation
- Workgroup 4. Delivery Strategies for Typhoid, JE, Rubella, and HPV Vaccines
- Workgroup 5. Optimizing immunization schedules: an operational perspective
- Workgroup 6. Human Resources for Immunization
- Panel Discussion
- Market Place